Bruce F Bell

Array ( [id] => 5638172 [patent_doc_number] => 20060069146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Imidazole derivatives modulating the sodium channels' [patent_app_type] => utility [patent_app_number] => 11/281864 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069146.pdf [firstpage_image] =>[orig_patent_app_number] => 11281864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803651 [patent_doc_number] => 20080015240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Acid Salt of Benzimidazole Derivative and Crystal Thereof' [patent_app_type] => utility [patent_app_number] => 11/667683 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12939 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015240.pdf [firstpage_image] =>[orig_patent_app_number] => 11667683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624508 [patent_doc_number] => 08003806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Integrin antagonists useful as anticancer agents' [patent_app_type] => utility [patent_app_number] => 11/270088 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003806.pdf [firstpage_image] =>[orig_patent_app_number] => 11270088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252843 [patent_doc_number] => 07579477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/266346 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 40468 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579477.pdf [firstpage_image] =>[orig_patent_app_number] => 11266346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 865218 [patent_doc_number] => 07368577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/266431 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 40467 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368577.pdf [firstpage_image] =>[orig_patent_app_number] => 11266431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638165 [patent_doc_number] => 20060069139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/266424 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 40453 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069139.pdf [firstpage_image] =>[orig_patent_app_number] => 11266424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927944 [patent_doc_number] => 20080167307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/667006 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 133531 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167307.pdf [firstpage_image] =>[orig_patent_app_number] => 11667006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221172 [patent_doc_number] => 07608718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => '4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity' [patent_app_type] => utility [patent_app_number] => 11/265090 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6505 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608718.pdf [firstpage_image] =>[orig_patent_app_number] => 11265090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777585 [patent_doc_number] => 20060106225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'N3 alkylated benzimidazole derivatives as MEK inhibitors' [patent_app_type] => utility [patent_app_number] => 11/258398 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13526 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106225.pdf [firstpage_image] =>[orig_patent_app_number] => 11258398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619398 [patent_doc_number] => 07999118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Process for producing N-halogenated hydantoins' [patent_app_type] => utility [patent_app_number] => 11/251640 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14516 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999118.pdf [firstpage_image] =>[orig_patent_app_number] => 11251640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 589332 [patent_doc_number] => 07439360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/251445 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33381 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439360.pdf [firstpage_image] =>[orig_patent_app_number] => 11251445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028685 [patent_doc_number] => 08143425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Heterocyclic aromatic compounds useful as growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 11/247491 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15298 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143425.pdf [firstpage_image] =>[orig_patent_app_number] => 11247491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705805 [patent_doc_number] => 20060194853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Alkyl benzamides' [patent_app_type] => utility [patent_app_number] => 11/244787 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194853.pdf [firstpage_image] =>[orig_patent_app_number] => 11244787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652251 [patent_doc_number] => 20080039507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Novel Prostamides For The Treatment Of Glaucoma And Related Diseases' [patent_app_type] => utility [patent_app_number] => 11/573692 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039507.pdf [firstpage_image] =>[orig_patent_app_number] => 11573692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748470 [patent_doc_number] => 20060111402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)' [patent_app_type] => utility [patent_app_number] => 11/235581 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32762 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111402.pdf [firstpage_image] =>[orig_patent_app_number] => 11235581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112099 [patent_doc_number] => 07718680 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Inhibition of lethal factor protease activity from anthrax toxin' [patent_app_type] => utility [patent_app_number] => 11/233924 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 16 [patent_no_of_words] => 11055 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718680.pdf [firstpage_image] =>[orig_patent_app_number] => 11233924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92625 [patent_doc_number] => 07732618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/230916 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30766 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732618.pdf [firstpage_image] =>[orig_patent_app_number] => 11230916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829227 [patent_doc_number] => 20060063814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Substituted hydantoins' [patent_app_type] => utility [patent_app_number] => 11/225950 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38534 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063814.pdf [firstpage_image] =>[orig_patent_app_number] => 11225950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910495 [patent_doc_number] => 07329684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Benzimidazole derivatives as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/225277 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15077 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329684.pdf [firstpage_image] =>[orig_patent_app_number] => 11225277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 591098 [patent_doc_number] => 07435831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Bicyclic and bridged nitrogen heterocycles' [patent_app_type] => utility [patent_app_number] => 11/219637 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 46366 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435831.pdf [firstpage_image] =>[orig_patent_app_number] => 11219637 [rel_patent_id] =>[rel_patent_doc_number] =>)